Defective production of functional 98-kDa form of Elf-1 is responsible for the decreased expression of TCR ζ-chain in patients with systemic lupus erythematosus

Journal of Immunology

Volumn 169, Issue 10, 2002, Pages 6048-6055

  Juang, Yuang Taung ^a   Tenbrock, Klaus ^a   Nambiar, Madhusoodana P ^a   Gourley, Mark F ^a   Tsokos, G C ^a  

^a Institute of Research   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CELL DNA; CYCLOPHOSPHAMIDE; GENE PRODUCT; HYDROXYCHLOROQUINE; PREDNISONE; T LYMPHOCYTE RECEPTOR; T LYMPHOCYTE RECEPTOR ZETA CHAIN; TRANSCRIPTION FACTOR ELF 1; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; AUTOIMMUNE DISEASE; CELL NUCLEUS; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOPLASM; FEMALE; GENE EXPRESSION; GENE FUNCTION; GENETIC TRANSCRIPTION; GLYCOSYLATION; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; RNA TRANSLATION; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE; T LYMPHOCYTE RECEPTOR GENE;

EID: 0037111374     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.169.10.6048     Document Type: Article

References (29)

1. Kammer, G. M., and G. C. Tsokos. 2002. Abnormal T lymphocytesignal transduction in systemic lupus erythematosus. Curr. Dir. Autoimmun. 5:131.
2. Liossis, S. N., X. Z. Ding, G. J. Dennis, and G. C. Tsokos. 1998. Altered pattern of TCR/CD3-mediated protein-tyrosyl phosphorylation in T cells from patients with systemic lupus erythematosus: Deficient expression of the T cell receptor ζ chain. J. Clin. Invest. 101:1448.
3. Irving, B. A., A. C. Chan, and A. Weiss. 1993. Functional characterization of a signal transducing motif present in the T cell antigen receptor ζ chain. J. Exp. Med. 177:1093.
4. Vassilopoulos, D., B. Kovacs, and G. C. Tsokos. 1995. TCR/CD3 complex-mediated signal transduction pathway in T cells and T cell lines from patients with systemic lupus erythematosus. J. Immunol. 155:2269.
5. Seitzer, U., K. Kayser, H. Hohn, P. Entzian. H. H. Wacker. S. Ploetz. H. D. Flad. J. Gerdes, and M. J. Maeurer. 2001. Reduced T-cell receptor CD3ζ-chain protein and sustained CD3ε expression at the site of mycobacterial infection. Immunology 104:269.
6. Rabinowich, H., M. Banks, T. E. Reichert. T. F. Logan, J. M. Kirkwood, and T. L. Whiteside. 1996. Expression and activity of signaling molecules in T lymphocytes obtained from patients with metastatic melanoma before and after interleukin 2 therapy. Clin. Cancer Res. 2:1263.
7. Takahashi, A., K. Kono, H. Amemiya, H. Iizuka, H. Fujii, and Y. Matsumoto. 2001. Elevated caspase-3 activity in peripheral blood T cells coexists with increased degree of T-cell apoptosis and down-regulation of TCR ζ molecules in patients with gastric cancer. Clin. Cancer Res. 7:74.
8. Gastman, B. R., D. E. Johnson, T. L. Whiteside, and H. Rabinowich. 1999. Caspase-mediated degradation of T-cell receptor ζ-chain. Cancer Res. 59:1422.
9. Rellahan, B. L., J. P. Jensen, T. K. Howcroft, D. S. Singer, E. Bonvini, and A. M. Weissman. 1998. Elf-I regulates basal expression from the T cell antigen receptor ζ-chain gene promoter. J. Immunol. 160:2794.
10. Sarafova. S., and G. Siu. 1999. A potential role for Elf-I in CD4 promoter function. J. Biol. Chem. 274:16126.
11. John, S., C. M. Robbins, and W. J. Leonard. 1996. An IL-2 response element in the human IL-2 receptor a chain promoter is a composite element that binds Stat5, EIf-I. HMG-I(Y) and a GATA family protein. EMBO J. 15:5627.
12. Wang, C. Y., A. G. Bassuk, L. H. Boise, C. B. Thompson, R. Bravo, and J. M. Leiden. 1994. Activation of the granulocyte-macrophage colony-stimulating factor promoter in T cells requires cooperative binding of Elf-1 and AP-I transcription factors. Mol. Cell. Biol. 14:1153.
13. Juang. Y. T., E. E. Solomou. B. Rellahan. and G. C. Tsokos. 2002. Phosphorylation and O-linked glycosylation of Elf-1 leads to its translocation to the nucleus and binding to the promoter of the TCR ζ-chain. J. Immunol. 168:2865.
14. Thompson. C. B., C. Y. Wang, I. C. Ho, P. R. Bohjanen, B. Petryniak, C. H. June, S. Miesfeldt, L. Zhang. G. J. Nabel. B. Karpinski, et al. 1992. cis-acting sequences required for inducible interleukin-2 enhancer function bind a novel Ets-related protein, Elf-I. Mol. Cell. Biol. 12:1043.
15. Gunther, C. V., and B. J. Graves. 1994. Identification of ETS domain proteins in murine T lymphocytes that interact with the Moloney murine leukemia virus enhancer. Mol. Cell. Biol. 14:7569.
16. Wong, H. K., G. M. Kammer, G. Dennis, and G. C. Tsokos. 1999. Abnormal NF-κB activity in T lymphocytes from patients with systemic lupus erythematosus is associated with decreased p65-ReIA protein expression. J. Immunol. 163:1682.
17. Solomou, E. E., Y. T. Juang, M. F. Gourley, G. M. Kammer, and G. C. Tsokos. 2001. Molecular basis of deficient IL-2 production in T cells from patients with systemic lupus erythematosus. J. Immunol. 166:4216.
18. Tan. E. M., A. S. Cohen, J. F. Fries, A. T. Masi, D. J. McShane. N. F. Rothfield, J. G. Schaller, N. Talal, and R. J. Winchester. 1982. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 25:1271.
19. Solomou, E. E., Y. T. Juang, and G. C. Tsokos. 2001. Protein kinase C-0 participates in the activation of cyclic AMP-responsive element-binding protein and its subsequent binding to the - 180 site of the IL-2 promoter in normal human T lymphocytes. J. Immunol. 166:5665.
20. Nambiar, M. P., E. J. Enyedy, V. G. Warke, S. Krishnan, G. Dennis, G. M. Kammer, and G. C. Tsokos. 2001. Polymorphisms/mutations of TCR-ζ-chain promoter and 3′ untranslated region and selective expression of TCR ζ-chain with an alternatively spliced 3′ untranslated region in patients with systemic lupus erythematosus. J. Autoimmun. 16:133.
21. Comer, F. I., and G. W. Hart. 1999. O-GIcNAc and the control of gene expression. Biochim. Biophys. Acta 1473:161.
22. Demetriou, M., M. Granovsky, S. Quaggin, and J. W. Dennis. 2001. Negative regulation of T-cell activation and autoimmunity by Mgat5 N-glycosylation. Nature 409:733.
23. Tada, Y., K. Nagasawa, Y. Yamauchi, H. Tsukamoto, and Y. Niho. 1991. A defect in the protein kinase C system in T cells from patients with systemic lupus erythematosus. Clin. Immunol. Immunopathol. 60:220.
24. Musti, A. M., M. Treier, and D. Bohmann. 1997. Reduced ubiquitin-dependent degradation of c-Jun after phosphorylation by MAP kinases. Science 275:400.
25. Nambiar. M. P., E. J. Enyedy, C. U. Fisher, V. G. Warke, Y. T. Juang, and G. C. Tsokos. 2001. Dexamethasone modulates TCR ζ chain expression and antigen receptor-mediated early signaling events in human T lymphocytes. Cell. Immunol. 208:62.
26. Nambiar, M. P., E. J. Enyedy, C. U. Fisher, V. G. Warke, and G. C. Tsokos. 2001. High dose of dexamethasone upregulates TCR/CD3-induced calcium response independent of TCR ζ chain expression in human T lymphocytes. J Cell. Biochem. 83:401.
27. Oettgen, P., Y. Akbarali, J. Boltax, J. Best, C. Kunsch, and T. A. Libermann. 1996. Characterization of NERF, a novel transcription factor related to the Ets factor ELF-1. Mol. Cell. Biol. 16:5091.
28. Serdobova, I., M. Pla, P. Reichenbach, P. Sperisen, J. Ghysdael, A. Wilson, J. Freeman, and M. Nabholz. 1997. Elf-1 contributes to the function of the complex interleukin (IL)-2-responsive enhancer in the mouse IL-2 receptor α gene. J. Exp. Med. 185:1211.
29. Wurster. A. L., G. Siu, J. M. Leiden. and S. M. Hedrick. 1994. Elf-1 binds to a critical element in a second CD4 enhancer. Mol. Cell. Biol. 14:6452.